Clinical studies recruiting near Rosario

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Phase 2 · Research Site · Alexion Pharmaceuticals, Inc. · NCT07157787 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Sanatorio Británico · Pfizer · NCT07028853 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Instituto de Oncologia de Rosario · Daiichi Sankyo · NCT07022483 A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · INECO · Takeda · NCT06747351 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Sanatorio Parque ( Site 0512) · Merck Sharp & Dohme LLC · NCT06393374 A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Phase 2/Phase 3 · Instituto CAICI SRL ( Site 3106) · Merck Sharp & Dohme LLC · NCT07266831 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Fundacion Estudios Clinicos · Pfizer · NCT06758401 A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · INECO Neurociencias Oroño · H. Lundbeck A/S · NCT05897320 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Instituto Medico Catamarca Imec · Amgen · NCT07037433 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · INECO Neurociencias Oroño · Eli Lilly and Company · NCT07415044 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Instituto de Oncologia de Rosario ( Site 0104) · Merck Sharp & Dohme LLC · NCT07216703 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Consultorios Integrados Rosario | Instituto Medico de la Fun · Bayer · NCT07192952 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Sanatorio Británico · Pfizer · NCT07144280 Efficacy of INM004 in Children With STEC-HUS
Phase 3 · Hospital de Niños Zona Norte "Dr. Roberto M. Carra" · Inmunova S.A. · NCT06389474 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Fundacion Estudios Clinicos-Oncology ( Site 2907) · Merck Sharp & Dohme LLC · NCT06077760 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0200 · Celgene · NCT05519085 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Hospital Provincial Del Centenario · Gilead Sciences · NCT06051617 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Hospital Privado de Rosario · Boehringer Ingelheim · NCT06531824 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · Sanatorio Parque SA · Amgen · NCT07005128 A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-0
Phase 3 · Sanatorio Parque ( Site 0251) · Merck Sharp & Dohme LLC · NCT07489495 A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Phase 2/Phase 3 · Sanatorio Nuestra Senora del Rosario ( Site 0104) · Merck Sharp & Dohme LLC · NCT07634471 A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Fundacion Estudios Clinicos ( Site 0304) · Merck Sharp & Dohme LLC · NCT06833073 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · INECO Neurociencias Oroño · Eli Lilly and Company · NCT07353931 A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate
Phase 3 · Teva Investigational Site 20148 · Teva Branded Pharmaceutical Products R&D LLC · NCT06664619 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal
Phase 3 · Centro de Investigaciones Clínicas - IESR - Rosario · Eli Lilly and Company · NCT06338995 A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT05757102 A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared t
Phase 2 · Research Site · AstraZeneca · NCT07525375 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Centro Médico IPAM ( Site 2452) · Merck Sharp & Dohme LLC · NCT06623422 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Sanatorio de la Mujer · Janssen Research & Development, LLC · NCT06319820

Look up another city

Look up another condition